Keywords: United Therapeutics, Sandoz, Novartis, Remodulin, Law suit, Hypertension

United Therapeutics sues Sandoz over Remodulin patent infringement

Article | 16 March 2012

Print This

United Therapeutics (Nasdaq: UTHR) says that it has filed a law suit in the US District Court for the District ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in